PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA

LAGUNA HILLS, Calif., Jan. 30, 2017 (GLOBE NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, officially announced today that PharmaCyte has retained Facet Life Sciences, Inc. (Facet) to guide PharmaCyte through [click to read the full story]

Virtual Regulatory Solutions Rebrands as Facet Life Sciences

Innovative Development Solutions Company Rebrands to Reflect Broad Product and Service Offerings Wayne, PA, January 10, 2017 – Virtual Regulatory Solutions, a leading provider of development solutions (software and services) for small and growing life sciences teams, today announced that the company is rebranding under the name, Facet Life Sciences. [click to read the full story]